NIH Extramural Nexus (News)

We seek your input on two resources aimed at supporting participants in NIH-funded implantable device clinical trials. Comments on this Request for Information are voluntary and should be submitted electronically until May 25, 2026. 

NIH is seeking public input on a framework for the NIH-Wide Strategic Plan for fiscal years 2027–2031 through a newly issued request for information (RFI) . This RFI provides an opportunity for the extramural research community to help inform NIH’s highest-level priorities and goals for the next five years. 

Have you explored our Fellowship opportunities? We wanted to remind you that NIH fellowships are open to early career scientists, including at the predoctoral and postdoctoral level.

We remain committed to ensuring safe, respectful, and harassment-free research environments wherever NIH-supported research is conducted. NIH grant recipients, through their institution’s leadership, faculty, and Authorized Organizational Representatives (AORs), are essential for sustaining this commitment.

NIH seeks community feedback through two webinars on the next agency-wide strategic plan. This plan will guide our work over the next five years to fulfill our mission for the American people. Input from the research community, stakeholders, and the public is essential to ensure transparency in what we do and advance the principles of gold standard science that we all apply to our daily work. 

Our Matchmaker tool in RePORTER can help you determine which institute or center may be interested in your idea, which NIH program official you may want to contact, and which study section you might suggest for application review. 

These Survey Results help inform NIH’s ongoing efforts to reduce time and effort spent by Institutional Animal Care and Use Committee (IACUC) administrators and principal investigators (PIs) while maintaining the integrity and credibility of research findings and protection of research animals.

NIH announced that Basic Experimental Studies with Humans (BESH) will no longer be considered clinical trials by the NIH. 

We are reporting on the number of early stage investigators (ESIs) supported on R01-equivalent awards in fiscal years (FYs) 2024 and 2025. ESIs are those who are within 10 years of their terminal degree or completion of clinical training and who have not yet been awarded a substantial NIH grant (R01-equivalent or more). 

NIH has launched a new resource focused on strengthening replication and reproducibility across NIH-funded research. The Strengthening Replication and Reproducibility of NIH-funded Research webpage serves as a centralized hub highlighting NIH’s ongoing efforts to promote rigorous, transparent, and reliable science.